181 related articles for article (PubMed ID: 11440333)
21. HIV-associated pulmonary arterial hypertension: from bedside to the future.
Correale M; Palmiotti GA; Lo Storto MM; Montrone D; Foschino Barbaro MP; Di Biase M; Lacedonia D
Eur J Clin Invest; 2015 May; 45(5):515-28. PubMed ID: 25715739
[TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus and hepatitis C virus co-infection.
Vlahakis SR
J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
[TBL] [Abstract][Full Text] [Related]
23. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
Scelsi L; Ghio S; Campana C; D'Armini AM; Serio A; Klersy C; Piovella F; Viganò M; Tavazzi L
Ital Heart J; 2004 Aug; 5(8):618-23. PubMed ID: 15554033
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary hypertension and HIV.
Proj Inf Perspect; 2002 Mar; (34):12-3. PubMed ID: 12038299
[TBL] [Abstract][Full Text] [Related]
25. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant.
Feiterna-Sperling C; Hüseman D; Timme J; Bührer C; Obladen M
Pediatr Infect Dis J; 2008 Jun; 27(6):564-7. PubMed ID: 18449067
[TBL] [Abstract][Full Text] [Related]
26. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C and human immunodeficiency virus infection.
Thomas DL
Hepatology; 2002 Nov; 36(5 Suppl 1):S201-9. PubMed ID: 12407595
[TBL] [Abstract][Full Text] [Related]
28. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
[TBL] [Abstract][Full Text] [Related]
29. [Epoprostenol in the treatment of portopulmonary hypertension].
Culafić D; Culafić-Vojinović V; Jesić R
Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
[TBL] [Abstract][Full Text] [Related]
30. Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension?
Gutiérrez F; Masiá M; Padilla S; Ramos JM; Bernal E; Morales P; Pozo F; Andrada E; Martin-Hidalgo A
J Clin Virol; 2006 Oct; 37(2):79-82. PubMed ID: 16884948
[TBL] [Abstract][Full Text] [Related]
31. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
Lung; 2001; 179(4):233-43. PubMed ID: 11891614
[TBL] [Abstract][Full Text] [Related]
32. Bosentan: new preparation. Pulmonary hypertension: an option before epoprostenol infusion.
Prescrire Int; 2005 Apr; 14(76):47-50. PubMed ID: 15875338
[TBL] [Abstract][Full Text] [Related]
33. HIV-associated pulmonary arterial hypertension: a clinical problem that is here to stay?
Murphy D; Girgis RE
Int J Clin Pract Suppl; 2009 Mar; (161):19-21. PubMed ID: 19178602
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
[TBL] [Abstract][Full Text] [Related]
35. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
Vallet-Pichard A; Pol S
J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil as treatment for Human Immunodeficiency Virus-related pulmonary hypertension in a child.
Wong AR; Rasool AH; Abidin NZ; Noor AR; Quah BS
J Paediatr Child Health; 2006 Mar; 42(3):147-8. PubMed ID: 16509918
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
38. Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.
Dickinson MG; Schölvinck EH; Boonstra A; Vonk-Noordegraaf A; Snijder RJ; Berger RM
J Heart Lung Transplant; 2009 Mar; 28(3):273-9. PubMed ID: 19285620
[TBL] [Abstract][Full Text] [Related]
39. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
Ciuffreda D; Pantaleo G; Pascual M
Transpl Int; 2007 Aug; 20(8):649-58. PubMed ID: 17425723
[TBL] [Abstract][Full Text] [Related]
40. [Effect of calcium channel antagonists in primary pulmonary hypertension in association with human immunodeficiency virus infection].
Bragulat E; García F; Fernández F; Ballester E; Villalta J; Grau JM
An Med Interna; 1998 Feb; 15(2):114. PubMed ID: 9542214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
